… issues associated with PML infection developing after rituximab treatment. Since the first
case series report of 52 cases of rituximab-associated PML among patients with non-Hodgkin …

… era, PML was an opportunistic infection almost exclusively diagnosed in AIDS patients.
PML in HIV-negative patients was driven from rarity to clinical mainstream thanks to iatrogenic …

… specific treatment for JC virus. 24 hours after we got the JCV positive results, patient received
… Complex supportive care was given to our patient, including antibiotic therapy and intrave…

… drugs such as Natalizumab, Rituximab, or Efalizumab for Crohn’… also been found in patients
receiving HAART therapy for HIV, … a median survival in HIV negative patients of 3 months [7]. …

… rituximab in HIV-negative patients is 1 in 1000 and 1 in 32 000, respectively. Incidence rates
of PML in patients on rituximab … to prevent JCV reactivation in patients on these medications. …

… with PML had GPA for 8 years and were HIV-negative. Both also had ≥ 1 known risk
factor … of rituximab treatment. Patient 1 had a history of breast cancer and treatment with …

… In a review of 57 HIV-negative lymphoma patients treated with rituximab who developed
PML, there was a 90% fatality rate within a median survival of 2.0 months. So far, the aim of …

… Progressive multifocal leukoencephalopathy (PML) is a rare … This case report describes a
case of a 35-year-old HIV-negative … complicated by IRIS secondary to Rituximab, which he had …

… rituximab. Magnetic resonance imaging of the brain with gadolinium was pathognomonic for
progressive multifocal leukoencephalopathy (… diagnostic workup of rituximab-induced PML …

… Progressive multifocal leukoencephalopathy (PML) is a … John Cunningham polyomavirus
in immunosuppressed patients. … disproportionate signal for rituximab. In a notable minority of …